Department of Ophthalmology, Flinders Health and Medical Research Institute, Flinders University, Adelaide, South Australia, Australia; email:
Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia; email:
Annu Rev Genomics Hum Genet. 2024 Aug;25(1):287-308. doi: 10.1146/annurev-genom-121222-105817. Epub 2024 Aug 6.
Glaucoma is a clinically heterogeneous disease and the world's leading cause of irreversible blindness. Therapeutic intervention can prevent blindness but relies on early diagnosis, and current clinical risk factors are limited in their ability to predict who will develop sight-threatening glaucoma. The high heritability of glaucoma makes it an ideal substrate for genetic risk prediction, with the bulk of risk being polygenic in nature. Here, we summarize the foundations of glaucoma genetic risk, the development of polygenic risk prediction instruments, and emerging opportunities for genetic risk stratification. Although challenges remain, genetic risk stratification will significantly improve glaucoma screening and management.
青光眼是一种临床表现多样的疾病,也是全球导致不可逆性失明的首要原因。治疗干预可以预防失明,但需要早期诊断,而目前的临床危险因素在预测哪些人会患上威胁视力的青光眼方面能力有限。青光眼的高遗传性使其成为遗传风险预测的理想基础,大部分风险是多基因性质的。在这里,我们总结了青光眼遗传风险的基础、多基因风险预测工具的发展以及遗传风险分层的新机遇。尽管仍存在挑战,但遗传风险分层将极大地改善青光眼的筛查和管理。